Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting

por Tremblay, Gabriel, Rousseau, Ben, Marquis, Miriam, Beaubois, Cyrielle, Sauvageau, Guy, Hébert, Josée
Publicado 2019

The Non-Classical MAP Kinase ERK3 Controls T Cell Activation

por Marquis, Miriam, Boulet, Salix, Mathien, Simon, Rousseau, Justine, Thébault, Paméla, Daudelin, Jean-François, Rooney, Julie, Turgeon, Benjamin, Beauchamp, Claudine, Meloche, Sylvain, Labrecque, Nathalie
Publicado 2014

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

por Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée
Publicado 2018

Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

por Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée
Publicado 2019